JPRN-C000000303未知未知
Romdomized study to evaluate the renoprotective effects of clarithromycin for diabetic patients with microalbuminuria. - The study of the renoprotective effects of clarithromycin for diabetic nephropathy.
Okayama university graduate school of medicine, dentistry and pharmaceutical sciences, Department of medicine and clinical science0 个研究点目标入组 40 人开始时间: 2005年12月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.CHF 2.Severe liver and/or kidney dysfunction 3.History of allergic response to drugs
研究者
相似试验
尚未招募
1 期
A clinical trial to study the effect of a polyherbomineral drug, Eladi Churna in patients with diabetic kidney disease.CTRI/2023/06/054530Dr Jupitora Dutta
进行中（未招募）
1 期
This study aims to investigate the potential beneficial effects on the kidney of a new medication called Dapagliflozin in type 2 diabetic patients.Diabetic NephropathyEUCTR2013-004042-42-GBKing’s College London40
已完成
不适用
An exploratory clinical study of the renoprotective effect of empagliflozin and the verification of companion diagnostics in type 2 diabetes patientsType 2 diabetes mellitusJPRN-UMIN000023902Department of Applied Molecular Medicine, Niigata University Graduate School of Medical and Dental Sciences51
进行中（未招募）
1 期
This study will assess the effects of dapagliflozin (a drug that is used in patients with Type 2 Diabetes) on lowering the level of urine protein in patients with non-diabetic kidney disease.Chronic kidney diseaseEUCTR2017-001090-16-NLniversity Medical Center Groningen53
已完成
3 期
A study to assess the renoprotective effects of the SGLT2 inhibitor Dapagliflozin in non-diabetic patients with proteinuria: a randomized double blind 6-week cross-over trialChronic kidney diseaseNL-OMON47662niversitair Medisch Centrum Groningen20